Stocks
Capricor Therapeutics, Inc.CAPR
NASDAQHealthcareBiotechnology$30.50-8.74%
A clinical-stage biotechnology company developing cell and exosome-based therapies for rare diseases, with a primary focus on treating Duchenne muscular dystrophy–related cardiomyopathy. Its lead candidate, deramiocel, is being studied to address cardiac complications associated with Duchenne, a key...
Market Cap: $1.4B52W Range: $4.30 – $40.37
This page tracks all publicly disclosed congressional trades in Capricor Therapeutics, Inc. (CAPR), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Congressional Trading History
No congressional trades found for this stock.